Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells
- Kresoja-Rakic, Jelena Laboratory of Molecular Oncology, Clinic of Oncology, University Hospital Zürich, Switzerland
- Kapaklikaya, Esra Laboratory of Molecular Oncology, Clinic of Oncology, University Hospital Zürich, Switzerland
- Ziltener, Gabriela Laboratory of Molecular Oncology, Clinic of Oncology, University Hospital Zürich, Switzerland
- Dalcher, Damian Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich, Switzerland
- Santoro, Raffaella Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich, Switzerland
- Christensen, Brock C. Departments of Epidemiology, Pharmacology and Toxicology and Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, USA
- Johnson, Kevin C. Departments of Epidemiology, Pharmacology and Toxicology and Community and Family Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, USA
- Schwaller, Beat Anatomy, Department of Medicine, University of Fribourg, Switzerland
- Weder, Walter Division of Thoracic Surgery, University Hospital Zürich, Switzerland
- Stahel, Rolf A. Laboratory of Molecular Oncology, Clinic of Oncology, University Hospital Zürich, Switzerland
- Felley-Bosco, Emanuela Laboratory of Molecular Oncology, Clinic of Oncology, University Hospital Zürich, Switzerland
-
01.02.2016
Published in:
- Oncotarget. - 2016, vol. 7, no. 16, p. 21272–21286
English
Calretinin (CALB2) is a diagnostic marker for epithelioid mesothelioma. It is also a prognostic marker since patients with tumors expressing high calretinin levels have better overall survival. Silencing of calretinin decreases viability of epithelioid mesothelioma cells. Our aim was to elucidate mechanisms regulating calretinin expression in mesothelioma. Analysis of calretinin transcript and protein suggested a control at the mRNA level. Treatment with 5-aza-2′-deoxycytidine and analysis of TCGA data indicated that promoter methylation is not likely to be involved. Therefore, we investigated CALB2 promoter by analyzing ~1kb of genomic sequence surrounding the transcription start site (TSS) + 1 using promoter reporter assay. Deletion analysis of CALB2 proximal promoter showed that sequence spanning the –161/+80bp region sustained transcriptional activity. Site-directed analysis identified important cis- regulatory elements within this –161/+80bp CALB2 promoter. EMSA and ChIP assays confirmed binding of NRF-1 and E2F2 to the CALB2 promoter and siRNA knockdown of NRF-1 led to decreased expression of calretinin. Cell synchronization experiment showed that calretinin expression was cell cycle regulated with a peak of expression at G1/S phase. This study provides the first insight in the regulation of CALB2 expression in mesothelioma cells.
- Faculty
- Faculté des sciences et de médecine
- Department
- Département de Médecine
- Language
-
- English
- Classification
- Biological sciences
- License
- License undefined
- Identifiers
-
- RERO DOC 277409
- DOI 10.18632/oncotarget.7114
- Persistent URL
- https://folia.unifr.ch/unifr/documents/305095
Statistics
Document views: 21
File downloads:
- sch_ict.pdf: 80